Mikkelsen Kristian H, Frost Morten, Bahl Martin I, Licht Tine R, Jensen Ulrich S, Rosenberg Jacob, Pedersen Oluf, Hansen Torben, Rehfeld Jens F, Holst Jens J, Vilsbøll Tina, Knop Filip K
Center for Diabetes Research, Gentofte Hospital, University of Copenhagen, Hellerup, Denmark.
NNF Centre for Basic Metabolic Research and Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
PLoS One. 2015 Nov 12;10(11):e0142352. doi: 10.1371/journal.pone.0142352. eCollection 2015.
The gut microbiota has been designated as an active regulator of glucose metabolism and metabolic phenotype in a number of animal and human observational studies. We evaluated the effect of removing as many bacteria as possible by antibiotics on postprandial physiology in healthy humans.
Meal tests with measurements of postprandial glucose tolerance and postprandial release of insulin and gut hormones were performed before, immediately after and 6 weeks after a 4-day, broad-spectrum, per oral antibiotic cocktail (vancomycin 500 mg, gentamycin 40 mg and meropenem 500 mg once-daily) in a group of 12 lean and glucose tolerant males. Faecal samples were collected for culture-based assessment of changes in gut microbiota composition.
Acute and dramatic reductions in the abundance of a representative set of gut bacteria was seen immediately following the antibiotic course, but no changes in postprandial glucose tolerance, insulin secretion or plasma lipid concentrations were found. Apart from an acute and reversible increase in peptide YY secretion, no changes were observed in postprandial gut hormone release.
As evaluated by selective cultivation of gut bacteria, a broad-spectrum 4-day antibiotics course with vancomycin, gentamycin and meropenem induced shifts in gut microbiota composition that had no clinically relevant short or long-term effects on metabolic variables in healthy glucose-tolerant males.
clinicaltrials.gov NCT01633762.
在多项动物和人体观察性研究中,肠道微生物群已被认定为葡萄糖代谢和代谢表型的活跃调节因子。我们评估了使用抗生素尽可能多地清除细菌对健康人体餐后生理的影响。
对12名体型偏瘦且糖耐量正常的男性进行了进餐测试,在服用为期4天的口服广谱抗生素鸡尾酒(万古霉素500毫克、庆大霉素40毫克和美罗培南500毫克,每日一次)之前、之后立即以及6周后,测量其餐后葡萄糖耐量、胰岛素和肠道激素的餐后释放情况。收集粪便样本,通过基于培养的方法评估肠道微生物群组成的变化。
抗生素疗程结束后,一组代表性肠道细菌的丰度立即出现急剧下降,但餐后葡萄糖耐量、胰岛素分泌或血浆脂质浓度未发现变化。除了肽YY分泌出现急性且可逆的增加外,餐后肠道激素释放未观察到变化。
通过对肠道细菌的选择性培养评估,使用万古霉素、庆大霉素和美罗培南进行为期4天的广谱抗生素疗程可导致肠道微生物群组成发生变化,但对健康糖耐量正常男性的代谢变量没有临床相关的短期或长期影响。
clinicaltrials.gov NCT01633762。